Seattle Genetics Q3 Loss Narrows - Quick Facts

(RTTNews) - Seattle Genetics, Inc. (SGEN) reported that its third-quarter net loss narrowed to $15.57 million or $0.13 per share from a loss of $23.69 million or $0.19 per share, last year.

On average, 15 analysts polled by Thomson Reuters expected the company to report a loss per share of $0.24 for the quarter. Analysts' estimates typically exclude special items.

Total revenues increased to $75.85 million from $70.97 million, a year ago. Analysts expected revenue of $66.92 million for the quarter.

Seattle Genetics anticipates that 2014 revenues from ADCETRIS net product sales in the U.S. and Canada will be higher than previously anticipated, and are now expected to be in the range of $172 million to $177 million. The company also anticipates that 2014 collaboration revenues will be higher than previously anticipated, and are now expected to be in the range of $64 million to $68 million.